Ligand Pharmaceuticals Ownership | Who Owns Ligand Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Ligand Pharmaceuticals Ownership Summary


Ligand Pharmaceuticals is owned by 80.58% institutional investors, 2.26% insiders, and 17.16% retail investors. Tudor investment corp et al is the largest institutional shareholder, holding 81.78% of LGND shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 5.99% of its assets in Ligand Pharmaceuticals shares.

LGND Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockLigand Pharmaceuticals80.58%2.26%17.16%
SectorHealthcare Stocks 232.86%10.65%-143.51%
IndustryBiotech Stocks 382.13%10.41%-292.54%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Tudor investment corp et al15.75M81.78%$17.70M
Blackrock2.87M16.19%$241.95M
Blackrock funding, inc. /de2.94M15.18%$555.91M
Vanguard group2.07M10.71%$392.11M
Janus henderson group1.02M5.51%$108.76M
State street749.36K3.89%$132.74M
Chicago capital561.67K2.85%$112.14M
Massachusetts financial services co /ma/507.02K2.62%$95.86M
Franklin resources496.16K2.56%$93.81M
Congress asset management co /ma504.64K2.56%$100.75M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Ashford capital management244.43K4.82%$43.30M
Villere st denis j188.87K4.16%$37.71M
Private capital management227.16K3.59%$40.24M
Ranger investment management269.98K3.50%$51.05M
Cardinal capital management llc /ct133.67K3.08%$11.26M
Chicago capital561.67K3.02%$112.14M
Rice hall james & associates294.49K2.84%$52.17M
Lisanti capital growth38.61K1.94%$7.71M
Essex investment management61.14K1.66%$10.83M
Penn capital management company95.46K1.48%$19.08M

Top Buyers

HolderShares% AssetsChange
Tudor investment corp et al15.75M0.03%15.75M
Fmr457.23K0.00%431.01K
Franklin resources496.16K0.02%266.30K
Victory capital management254.81K0.03%222.00K
Invesco378.30K0.01%148.44K

Top Sellers

HolderShares% AssetsChange
Macquarie group---751.79K
Cardinal capital management llc /ct133.67K3.08%-425.56K
William blair investment management---205.69K
Knott david m jr---85.00K
Man group---68.66K

New Positions

HolderShares% AssetsChangeValue
Tudor investment corp et al15.75M0.03%15.75M$17.70M
Fiera capital131.24K0.08%131.24K$24.81M
Vanguard fiduciary trust127.90K0.01%127.90K$25.54M
Norges bank46.29K0.00%46.29K$4.96M
Trexquant investment lp44.50K0.08%44.50K$7.88M

Sold Out

HolderChange
Flagship harbor advisors-1.00
Mendota financial group-1.00
Optima capital-3.00
Cgc financial services-3.00
Tidemark-4.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 2025275-12.97%15,606,007-23.88%800.71%137-16.97%91-8.08%
Sep 30, 202530215.71%36,213,42492.32%1881.97%16315.60%887.32%
Jun 30, 20252662.31%19,162,9152.69%991.05%14410.77%82-5.75%
Mar 31, 2025258-1.53%18,645,9442.31%970.99%128-15.23%8846.67%
Dec 31, 2024239-2.85%16,852,409-6.71%910.95%135-577.55%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF1.20M5.99%255.00
Delaware Small Cap Core I655.86K3.59%-57.44K
Macquarie Small Cap Core I670.37K3.44%-14.18K
Janus Henderson US SMID Cap Growth MA596.82K3.09%596.78K
Vanguard Total Stock Mkt Idx Inv594.92K2.98%3.91K
Vanguard US Total Market Shares ETF529.85K2.75%-
Franklin Innovation Composite525.00K2.65%75.00K
Franklin DynaTech A525.00K2.63%75.00K
Janus Henderson Triton D498.06K2.50%-32.83K
Janus Henderson US SMID Cap Growth486.18K2.43%-44.71K

Recent Insider Transactions


DateNameRoleActivityValue
May 01, 2026Reardon Andrew CLO & SecretarySell$22.51K
May 01, 2026Reardon Andrew CLO & SecretarySell$85.42K
May 01, 2026Reardon Andrew CLO & SecretarySell$136.47K
May 01, 2026Reardon Andrew CLO & SecretarySell$213.20K
May 01, 2026Reardon Andrew CLO & SecretarySell$180.99K

Insider Transactions Trends


DateBuySell
2026 Q2-11
2026 Q1-42
2025 Q4-18
2025 Q3-8
2025 Q253

LGND Ownership FAQ


Who Owns Ligand Pharmaceuticals?

Ligand Pharmaceuticals shareholders are primarily institutional investors at 80.58%, followed by 2.26% insiders and 17.16% retail investors. The average institutional ownership in Ligand Pharmaceuticals's industry, Biotech Stocks , is 382.13%, which Ligand Pharmaceuticals falls below.

Who owns the most shares of Ligand Pharmaceuticals?

Ligand Pharmaceuticals’s largest shareholders are Tudor investment corp et al (15.75M shares, 81.78%), Blackrock (2.87M shares, 16.19%), and Blackrock funding, inc. /de (2.94M shares, 15.18%). Together, they hold 113.16% of Ligand Pharmaceuticals’s total shares outstanding.

Does Blackrock own Ligand Pharmaceuticals?

Yes, BlackRock owns 16.19% of Ligand Pharmaceuticals, totaling 2.87M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 241.95M$. In the last quarter, BlackRock increased its holdings by 3.23K shares, a 0.11% change.

Who is Ligand Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Ashford capital management is Ligand Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 4.82% of its assets in 244.43K Ligand Pharmaceuticals shares, valued at 43.3M$.

Who is the top mutual fund holder of Ligand Pharmaceuticals shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Ligand Pharmaceuticals shares, with 5.99% of its total shares outstanding invested in 1.2M Ligand Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools